Preoperative transarterial chemoembolization for hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2295-2299

  Kishi, Yoji ^a   Saiura, Akio ^a   Yamamoto, Junji ^b   Koga, Rintaro ^a   Seki, Makoto ^a   Morimura, Ryo ^a   Yoshioka, Ryuji ^a   Kokudo, Norihiro ^c   Yamaguchi, Toshiharu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hepatocellular carcinoma; Preoperative transarterial chemoembolization recurrent; Prognosis

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; BLEEDING; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CHEMOEMBOLIZATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872059422     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10730     Document Type: Article

References (28)

1. Arii S, Teramoto K, Kawamura T, et al.: Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg 2001; 8:397-403.
2. Harada T, Matsuo K, Inoue T, Tamesue S, Nakamura H: Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996; 224:4-9.
3. Gerunda GE, Neri D, Merenda R, et al.: Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transpl 2000; 6:619-626.
4. Choi GH, Kim DH, Kang CM, et al.: Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma? World J Surg 2007; 31:2370-2377.
5. Zhou WP, Lai EC, Li AJ, et al.: A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009; 249:195-202.
6. Lee KT, Lu YW, Wang SN, et al.: The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes. J Surg Oncol 2009; 99:343-350.
7. Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M: Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 2006; 32:773-779.
8. Kim IS, Lim YS, Lee HC, Suh DJ, Lee YJ, Lee SG: Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Aliment Pharmacol Ther 2008; 27:338-345.
9. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'Eng FK: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995; 82:122-126.
10. Chen XP, Hu DY, Zhang ZW, et al.: Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma. Dig Surg 2007; 24:208-213.
11. Minagawa M, Makuuchi M, Takayama T, Ohtomo K: Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233:379-384.
12. Sugo H, Futagawa S, Beppu T, Fukasawa M, Kojima K: Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg 2003; 27:1295-1299.
13. Kaibori M, Tanigawa N, Matsui V, et al.: influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. Anticancer Res 2006; 26:3685-3692.
14. Kishi Y, Saiura A, Yamamoto J, et al.: Is hepatic resection for recurrent or persistent hepatocellular carcinoma justified? Hepato-gastroenterol 2012; 59:2255-2259.
15. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T: Criteria for safe hepatic resection. Am J Surg 1995; 169:589-594.
16. Couinaud C: Le foie: études anatomiques et chirugicales. Paris: Masson, 1957.
17. Adachi E, Matsumata T, Nishizaki T, et al.: Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 1993; 72:3593-3598.
18. Matsui O, Kadoya M, Yoshikawa J, et al.: Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188:79-83.
19. Uchida M, Kohno H, Kubota H, et al.: Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 1996; 20:326-331.
20. Sakurai M, Okamura J, Kuroda C: Transcatheter chemoembolization effective for treating hepatocellular carcinoma. A histopathological study. Cancer 1984; 54:387-392.
21. Okano A, Hajiro K, Takakuwa H, et al.: Diffuse intrahepatic recurrence after resection of hepatocellular carcinoma. Hepatogastroenterol 2000; 47:1356-1359.
22. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL: Anterior approach for difficult major right hepatectomy. World J Surg 1996; 20:314-317 (discussion 8).
23. Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J: Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg 2006; 244:194-203.
24. Ishizawa T, Kokudo N, Makuuchi M: Right hepatectomy for hepatocellular carcinoma: is the anterior approach superior to the conventional approach? Ann Surg 2008; 247:390-391 (author reply 1-2).
25. Fan J, Tang ZY, Yu YQ, et al.: Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg 1998; 15:674-678.
26. Lau WY, Leung TW, Lai BS, et al.: Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma. Ann Surg 2001; 233:236-241.
27. Xiao EH, Guo D, Bian DJ: Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells. World J Gastroenterol 2009; 15:4582-4586.
28. Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M: The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000; 89:2606-2612.